Zobrazeno 1 - 10
of 607
pro vyhledávání: '"Wolfgang A, Weber"'
Autor:
Amir Karimzadeh, Charlotte-Sophie Hecker, Matthias M. Heck, Robert Tauber, Calogero D’Alessandria, Wolfgang A. Weber, Matthias Eiber, Isabel Rauscher
Publikováno v:
EJNMMI Research, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Background The optimal regimen for 177Lu-labeled prostate-specific membrane antigen-targeted radioligand therapy, including treatment intervals, remains under study, with evidence suggesting shorter intervals could benefit patients with high
Externí odkaz:
https://doaj.org/article/31e329c31e0949a1906aa3f3aad0cf6d
Autor:
Hui Wang, Marianne Remke, Thomas Horn, Kristina Schwamborn, Yiyao Chen, Katja Steiger, Wilko Weichert, Hans-Jürgen Wester, Margret Schottelius, Wolfgang A. Weber, Matthias Eiber
Publikováno v:
EJNMMI Research, Vol 13, Iss 1, Pp 1-12 (2023)
Abstract Background Targeting prostate-specific membrane antigen (PSMA) has been highly successful for imaging and treatment of prostate cancer. However, heterogeneity in immunohistochemistry indicates limitations in the effect of imaging and radionu
Externí odkaz:
https://doaj.org/article/e730479a683c4bf18070e7f31822ee14
Autor:
Carolin Kitzberger, Khuram Shehzad, Volker Morath, Rebekka Spellerberg, Julius Ranke, Katja Steiger, Roland E. Kälin, Gabriele Multhoff, Matthias Eiber, Franz Schilling, Rainer Glass, Wolfgang A. Weber, Ernst Wagner, Peter J. Nelson, Christine Spitzweg
Publikováno v:
Molecular Therapy: Oncolytics, Vol 30, Iss , Pp 238-253 (2023)
New treatment strategies are urgently needed for glioblastoma (GBM)—a tumor resistant to standard-of-care treatment with a high risk of recurrence and extremely poor prognosis. Based on their intrinsic tumor tropism, adoptively applied mesenchymal
Externí odkaz:
https://doaj.org/article/d524b87cfd2b4c978c114bf543db85aa
Autor:
Borjana Bogdanovic, Esteban L. Solari, Alberto Villagran Asiares, Sandra van Marwick, Sylvia Schachoff, Matthias Eiber, Wolfgang A. Weber, Stephan G. Nekolla
Publikováno v:
European Journal of Hybrid Imaging, Vol 7, Iss 1, Pp 1-12 (2023)
Abstract Background In patients with increasing PSA and suspicion for prostate cancer, but previous negative biopsies, PET/MRI is used to test for tumours and target potential following biopsy. We aimed to determine different PSMA PET timing effects
Externí odkaz:
https://doaj.org/article/cee995b42dee4f4b9c9f999666919d71
Autor:
Rebekka Spellerberg, Teoman Benli-Hoppe, Carolin Kitzberger, Mara Hageneier, Nathalie Schwenk, Özgür Öztürk, Katja Steiger, Gabriele Multhoff, Matthias Eiber, Franz Schilling, Wolfgang A. Weber, Roland E. Kälin, Rainer Glass, Peter J. Nelson, Ernst Wagner, Christine Spitzweg
Publikováno v:
Molecular Therapy: Oncolytics, Vol 27, Iss , Pp 272-287 (2022)
Sodium iodide symporter (NIS) gene transfer for active accumulation of iodide in tumor cells is a powerful theranostic strategy facilitating both diagnostic and therapeutic application of radioiodide. In glioblastoma (GBM), the blood-brain barrier (B
Externí odkaz:
https://doaj.org/article/a363261d210f4561be309e89accd3fb1
Autor:
Benedikt Feuerecker, Andrei Gafita, Thomas Langbein, Robert Tauber, Christof Seidl, Frank Bruchertseifer, Jürgen E. Gschwendt, Wolfgang A. Weber, Calogero D’Alessandria, Alfred Morgenstern, Matthias Eiber
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 23, p 16845 (2023)
Most Prostate Specific Membrane Antigens (PSMAs) targeting small molecules accumulate in the salivary glands (SGs), raising concerns about SG toxicity, especially after repeated therapies or therapy with 225Ac-labeled ligands. SG toxicity is assessed
Externí odkaz:
https://doaj.org/article/8679634db1754150a73ed6bafa3890e2
Autor:
Carolin Kitzberger, Rebekka Spellerberg, Volker Morath, Nathalie Schwenk, Kathrin A. Schmohl, Christina Schug, Sarah Urnauer, Mariella Tutter, Matthias Eiber, Franz Schilling, Wolfgang A. Weber, Sibylle Ziegler, Peter Bartenstein, Ernst Wagner, Peter J. Nelson, Christine Spitzweg
Publikováno v:
EJNMMI Research, Vol 12, Iss 1, Pp 1-14 (2022)
Abstract Cloning of the sodium iodide symporter (NIS) in 1996 has provided an opportunity to use NIS as a powerful theranostic transgene. Novel gene therapy strategies rely on image-guided selective NIS gene transfer in non-thyroidal tumors followed
Externí odkaz:
https://doaj.org/article/7399ed72a2d84c20be101a3d6215c0fb
Publikováno v:
Frontiers in Psychology, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/94928157eb834088aef7bc2a57f87b83
Autor:
Alexander Rühle, Anca-L. Grosu, Nicole Wiedenmann, Juri Ruf, Birgit Bieber, Raluca Stoian, Andreas R. Thomsen, Eleni Gkika, Peter Vaupel, Dimos Baltas, Wolfgang A. Weber, Michael Mix, Nils H. Nicolay
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 33, Iss , Pp 120-127 (2022)
Background: Tumor hypoxia worsens the prognosis of head-and-neck squamous cell carcinoma (HNSCC) patients, and plasma hypoxia markers may be used as biomarkers for radiotherapy personalization. We therefore investigated the role of the hypoxia-associ
Externí odkaz:
https://doaj.org/article/609bfa9ad90f490aa4546f8f6f71895f
Autor:
Volker Morath, Michael Heider, Markus Mittelhäuser, Hannes Rolbieski, Jacob Stroh, Jérémie Calais, Matthias Eiber, Florian Bassermann, Wolfgang A. Weber
Publikováno v:
EJNMMI Research, Vol 12, Iss 1, Pp 1-6 (2022)
Abstract Rationale Multiple myeloma (MM) cells synthesize large amounts of paraproteins, making radiolabeled amino acids promising candidates for PET imaging of MM patients. Methods We compare tumor uptake of the two amino acid analogs [18F]-fluoroet
Externí odkaz:
https://doaj.org/article/d92237fbfef2466cbc8efc3828da9c92